成人高级别脊髓胶质瘤中H3 K27M突变的预后价值:多中心分析
该多中心回顾性队列纳入30例成人弥漫性高级别脊髓胶质瘤患者,分析H3 K27M突变对无进展生存期和总生存期的影响。结果显示突变状态整体与预后无显著差异,但在含坏死和/或微血管增生的WHO IV级组织学特征亚组中,突变阳性者总生存期更优。
要点
- 成人高级别脊髓胶质瘤中H3 K27M突变整体与PFS和OS无显著相关。
- 同步放化疗及初诊ASIA C级或更好与生存期延长显著相关。
- 含WHO IV级组织学特征者中,H3 K27M突变阳性与OS改善相关。
核心结论
- H3 K27M突变阳性成人高级别脊髓胶质瘤总体预后仍差,但相较突变阴性者似略好。
研究设计与样本
- 多中心回顾性队列研究,纳入2000年1月至2020年7月六家三级学术中心30例成人弥漫性高级别脊髓胶质瘤患者。
主要发现
- 中位(范围)年龄50.5(19-76)岁,18例H3 K27M突变阳性,12例阴性。
- 中位(四分位距)PFS为3(10)个月,中位(四分位距)OS为9(23)个月。
- 同步化疗/放疗与PFS(p=0.006)和OS(p≤0.001)改善相关。
- 初诊ASIA C级或更好与PFS(p=0.043)和OS(p<0.001)改善相关。
- 肿瘤位置、切除程度、性别及H3 K27M突变状态与结局无显著差异。
临床怎么用
- 成人高级别脊髓胶质瘤应检测H3 K27M突变,并结合组织学分级解读预后。
- 同步放化疗可能改善生存,初诊ASIA分级可辅助预后评估。
局限性
- 样本量小(30例),为回顾性多中心设计。
- H3 K27M突变阳性与阴性亚组比较需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: High-grade spinal glioma (HGSG) is a rare but aggressive tumor that occurs in both adults and children. Histone H3 K27M mutation correlates with poor prognosis in children with diffuse midline glioma. However, the role of H3 K27M mutation in the prognosis of adults with HGSG remains unclear owing to the rarity of this mutation, conflicting reports, and the absence of multicenter studies on this topic. METHODS: The authors studied a cohort of 30 adult patients with diffuse HGSG who underwent histological confirmation of diagnosis, surgical intervention, and treatment between January 2000 and July 2020 at six tertiary academic centers. The primary outcome was the effect of H3 K27M mutation status on progression-free survival (PFS) and overall survival (OS). RESULTS: Thirty patients (18 males and 12 females) with a median (range) age of 50.5 (19-76) years were included in the analysis. Eighteen patients had H3 K27M mutation-positive tumors, and 12 had H3 K27M mutation-negative tumors. The median (interquartile range) PFS was 3 (10) months, and the median (interquartile range) OS was 9 (23) months. The factors associated with increased survival were treatment with concurrent chemotherapy/radiation (p = 0.006 for PFS, and p ≤ 0.001 for OS) and American Spinal Injury Association grade C or better at presentation (p = 0.043 for PFS, and p < 0.001 for OS). There were no significant differences in outcomes based on tumor location, extent of resection, sex, or H3 K27M mutation status. Analysis restricted to HGSG containing necrosis and/or microvascular proliferation (WHO grade IV histological features) revealed increased OS for patients with H3 K27M mutation-positive tumors (p = 0.017). CONCLUSIONS: Although H3 K27M mutant-positive HGSG was associated with poor outcomes in adult patients, the outcomes of patients with H3 K27M mutant-positive HGSG were somewhat more favorable compared with those of their H3 K27M mutant-negative HGSG counterparts. Further preclinical animal studies and larger clinical studies are needed to further understand the age-dependent effects of H3 K27M mutation.
引用
- Akinduro OO, Garcia DP, Higgins DMO, et al. A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal glioma. J Neurosurg Spine. 2021. PMID: 34416733. doi:10.3171/2021.2.SPINE201675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。